James Shin
Stock Analyst at Deutsche Bank
(2.76)
# 1,793
Out of 5,115 analysts
23
Total ratings
60%
Success rate
22.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $110.27 | +0.66% | 3 | Nov 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $1,037.15 | -13.22% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $9.55 | +4.71% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $141.95 | -15.46% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $341.88 | -10.79% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $100.07 | -40.04% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $55.05 | -18.26% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $17.50 | +242.86% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $223.01 | -32.74% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $741.45 | +7.90% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.37 | +629.93% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $14.95 | +702.68% | 1 | Nov 9, 2023 |
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $110.27
Upside: +0.66%
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $1,037.15
Upside: -13.22%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $9.55
Upside: +4.71%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $141.95
Upside: -15.46%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $341.88
Upside: -10.79%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $100.07
Upside: -40.04%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $55.05
Upside: -18.26%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $17.50
Upside: +242.86%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $223.01
Upside: -32.74%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $741.45
Upside: +7.90%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
Nov 9, 2023
Initiates: Buy
Price Target: $120
Current: $14.95
Upside: +702.68%